These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 1222391)
1. Letter: Cardiotoxicity of 5-fluorouracil (NSC-19893). Roth A; Kolaric K; Popovic S Cancer Chemother Rep; 1975; 59(6):1051-2. PubMed ID: 1222391 [No Abstract] [Full Text] [Related]
2. Cardiotoxicity resembling myocardial infarction that occurs during chemotherapy with 5-fluorouracil. Gul M; Duzenli A; Bircan M; Cander B; Kocak S; Ozdemir K Saudi Med J; 2005 Nov; 26(11):1821-2. PubMed ID: 16311676 [No Abstract] [Full Text] [Related]
4. Bolus 5-Fluorouracil as an alternative modality to infusion 5-Fluorouracil in a patient with rectal cancer and capecitabine-induced cardiotoxicity. Shaib W; Lee V; Saif MW In Vivo; 2009; 23(5):821-6. PubMed ID: 19779118 [TBL] [Abstract][Full Text] [Related]
5. The syndrome of 5-fluorouracil cardiotoxicity: an elusive cardiopathy. Weidmann B; Teipel A; Niederle N Cancer; 1994 Apr; 73(7):2001-2. PubMed ID: 8137229 [No Abstract] [Full Text] [Related]
6. Capecitabine-related cardiotoxicity: recognition and management. Saif MW; Tomita M; Ledbetter L; Diasio RB J Support Oncol; 2008 Jan; 6(1):41-8. PubMed ID: 18257400 [No Abstract] [Full Text] [Related]
7. Feasibility of 5-Fluorouracil resumption in a patient experiencing drug-induced acute Prinzmetal angina. Dongiovanni V; Spinnler MT; Ardine M Acta Oncol; 2006; 45(2):220-1. PubMed ID: 16546873 [No Abstract] [Full Text] [Related]
8. A case of 5-fluorouracil-induced peripheral neuropathy. Werbrouck BF; Pauwels WJ; De Bleecker JL Clin Toxicol (Phila); 2008 Mar; 46(3):264-6. PubMed ID: 18344111 [TBL] [Abstract][Full Text] [Related]
9. Phase II trial of 5-fluorouracil plus melphalan in colorectal carcinoma. Presant CA; Ratkin G; Klahr C Cancer Treat Rep; 1978 Mar; 62(3):461-2. PubMed ID: 348317 [No Abstract] [Full Text] [Related]
11. [Acute cardiotoxicity from 5-fluorouracil: un underestimated toxicity]. Bertolini A; Fiumanò M; Muffatti A; Pedroncelli S; Doria A; Codazzi G; Giustiniani S; Scarinci A; Redaelli G Minerva Cardioangiol; 1999; 47(7-8):269-73. PubMed ID: 10582438 [TBL] [Abstract][Full Text] [Related]
12. [Does 5-fluorouracil cardiotoxicity exist? Presentation of 2 cases with acute manifestations and clinico-instrumental study of 12 cases in chronic treatment with 5-fluorouracil]. Pinelli G; Lusa AM; Salvarani R; Di Pasquale G; Roncuzzi R; Coluccini M Minerva Cardioangiol; 1984 Sep; 32(9):627-30. PubMed ID: 6514209 [No Abstract] [Full Text] [Related]
13. Combination with 5-fluorouracil, methyl-CCNU and beta-2-deoxythioguanosine in advanced colo-rectal adenocarcinoma. Cedermark BJ; Kaufman JH; Douglass HO; Mittelman A Clin Oncol; 1977 Mar; 3(1):27-31. PubMed ID: 862274 [No Abstract] [Full Text] [Related]
14. Cardiotoxicity of 5-fluoro-uracil. A case report. Vorobiof DA S Afr Med J; 1982 Apr; 61(17):634-5. PubMed ID: 7079856 [TBL] [Abstract][Full Text] [Related]